1. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. (31st March 2022) Authors: Xing, Yajing; Guo, Weikai; Wu, Min; Xie, Jiuqing; Huang, Dongxia; Hu, Pan; Zhou, Miaoran; Zhang, Lin; Zhang, Qiansen; Wang, Peili; Wang, Xin; Wang, Guixue; Wu, Huangan; Zhou, Cili; Chen, Yihua; Liu, Mingyao; Yi, Zhengfang; Sun, Zhenliang Journal: Cancer letters Issue: Volume 529(2022) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells" [Cancer Lett. 414 (1 February 2018) 278–293]. (28th January 2022) Authors: Cao, Rui; Wang, Gang; Qian, Kaiyu; Chen, Liang; Ju, Lingao; Qian, Guofeng; Wu, Chin-Lee; Dan, Han C.; Jiang, Wei; Wu, Min; Xiao, Yu; Wang, Xinghuan Journal: Cancer letters Issue: Volume 525(2022) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EGFR-mediated autophagy in tumourigenesis and therapeutic resistance. (28th January 2020) Authors: Wu, Min; Zhang, Pinghu Journal: Cancer letters Issue: Volume 469(2020) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma. (28th June 2022) Authors: Fei, Keke; Ni, Haiqing; Zhu, Mengjia; Kuang, Zhihui; Wu, Min; Wu, Zhihai; Wang, Feifei; Zhou, Shuaixiang; Jing, Hua; Wu, Weiwei; Wu, Dongdong; Bai, Dongmei; Chen, Bingliang Journal: Cancer letters Issue: Volume 536(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth. Issue 1 (1st March 2016) Authors: Xu, Zhuobin; Wang, Zegen; Jia, Xuelian; Wang, Luxuan; Chen, Zhiguo; Wang, Shijing; Wang, Min; Zhang, Juan; Wu, Min Journal: Cancer letters Issue: Volume 372:Issue 1(2016) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation. (28th December 2017) Authors: Zhuang, Zhuonan; Li, Hao; Lee, Harold; Aguilar, Mitzi; Gocho, Takashi; Ju, Huaiqiang; Iida, Tomonori; Ling, Jianhua; Fu, Jie; Wu, Min; Sun, Yichen; Lu, Yu; Chiao, Paul J. Journal: Cancer letters Issue: Volume 411(2018) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models. (28th November 2017) Authors: Wang, Shijing; Zhou, Rihong; Sun, Fumou; Li, Renjie; Wang, Min; Wu, Min Journal: Cancer letters Issue: Volume 409(2017) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells. (1st February 2018) Authors: Cao, Rui; Wang, Gang; Qian, Kaiyu; Chen, Liang; Ju, Lingao; Qian, Guofeng; Wu, Chin-Lee; Dan, Han C.; Jiang, Wei; Wu, Min; Xiao, Yu; Wang, Xinghuan Journal: Cancer letters Issue: Volume 414(2018) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗